Home / Companies / Results / GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing

Premium

Photo: Reuters

1 min read Last Updated : May 17 2022 | 1:05 AM IST

GlaxoSmithKline Pharmaceuticals on Monday reported a consolidated net loss of Rs 55 crore from continuing operations for the March quarter (Q4FY22). The drug firm had reported a net profit of Rs 4 crore for Q4FY21.

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing.

For the financial year ended March 31, 2022, the company posted a consolidated net profit from continuing operations at Rs 381 crore, against Rs 287 crore in FY21.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : GlaxoSmithKline Pharmaceuticals Pharma Companies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in